A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : ELF

Search Conditions:
Search Keyword : ELF
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: ELF
Appearance Frequency: 1523 time(s)
Long forms: 80

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
epithelial lining fluid
(520 times)
Drug Therapy
(150 times)
BAL (102 times)
BALF (47 times)
AM (40 times)
1986 Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke.
extremely low frequency
(433 times)
Biophysics
(145 times)
MF (57 times)
EMF (46 times)
RF (33 times)
1977 A non-operative salvage of surgically-resistant pseudarthroses and non-unions by pulsing electromagnetic fields. A preliminary report.
electron localization function
(266 times)
Chemistry
(214 times)
AIM (41 times)
NBO (30 times)
QTAIM (30 times)
1999 Linking Intermetallics and Zintl Compounds: An Investigation of Ternary Trielides (Al, Ga, In) Forming the NaZn(13) Structure Type.
enhanced liver fibrosis
(101 times)
Gastroenterology
(40 times)
HA (14 times)
NAFLD (14 times)
TE (14 times)
2008 Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.
embryonic liver fodrin
(17 times)
Neoplasms
(6 times)
HCC (7 times)
TGF-beta (6 times)
TBRII (3 times)
2004 Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
etoposide, leucovorin and 5-fluorouracil
(17 times)
Neoplasms
(9 times)
CR (2 times)
PR (2 times)
5-FU (1 time)
1991 Management of esophageal, gastric, pancreatic, and hepatobiliary neoplasms.
extremely low frequency electromagnetic radiation
(17 times)
Occupational Medicine
(3 times)
TAMMEF (3 times)
EMFs (2 times)
OA (2 times)
1987 Cancer incidence among welders: possible effects of exposure to extremely low frequency electromagnetic radiation (ELF) and to welding fumes.
enzyme-labeled fluorescence
(13 times)
Histocytochemistry
(3 times)
DOP (2 times)
LNA (2 times)
AP (1 time)
1995 Use of a new fluorogenic phosphatase substrate in immunohistochemical applications.
endoluminal fundoplication
(9 times)
General Surgery
(5 times)
GERD (6 times)
GEV (1 time)
LARS (1 time)
2006 Endoluminal fundoplication (ELF)--evolution of EsophyX, a new surgical device for transoral surgery.
10  endogenous leucine flux
(8 times)
Endocrinology
(3 times)
NOLD (6 times)
LO (4 times)
ASR (2 times)
1990 Leucine metabolism in IDDM. Role of insulin and substrate availability.
11  European Lead Factory
(8 times)
Pharmacology
(3 times)
HTS (4 times)
MST (1 time)
PPP (1 time)
2015 MCR synthesis of a tetracyclic tetrazole scaffold.
12  epididymal luminal fluid
(6 times)
Reproductive Medicine
(5 times)
PMCA4 (2 times)
CASK (1 time)
GPI (1 time)
2000 Inductively coupled plasma emission spectroscopic and flame photometric analysis of goat epididymal fluid.
13  energy loss function
(5 times)
Nuclear Medicine
(1 time)
IMFPs (2 times)
EAL (1 time)
EELS (1 time)
2012 Electron energy loss spectra and overestimation of inelastic mean free paths in many-pole models.
14  E74-like factor
(4 times)
Molecular Biology
(2 times)
FOXO (1 time)
HCs (1 time)
HPV (1 time)
2010 Cutting edge: Expression of the transcription factor E74-like factor 4 is regulated by the mammalian target of rapamycin pathway in CD8+ T cells.
15  elimination of lymphatic filariasis
(4 times)
Communicable Diseases
(1 time)
DEC (2 times)
MDA (2 times)
mf (2 times)
2008 Locomotor disability in bancroftian filarial lymphoedema patients.
16  Evaluative Linguistic Framework
(4 times)
Pharmacology
(1 time)
ELF-Q (1 time)
RA (1 time)
2009 Patient assessment of medication information leaflets and validation of the Evaluative Linguistic Framework (ELF).
17  early liver failure
(3 times)
Gastroenterology
(2 times)
MLF (2 times)
DB (1 time)
DBPTRI (1 time)
2014 A Simple Index to Predict Liver Functional Reserve after Hepatectomy.
18  Endolichenic fungi
(3 times)
Biotechnology
(1 time)
--- 2017 Endolichenic Fungi: A Hidden Reservoir of Next Generation Biopharmaceuticals.
19  Enhanced Liver Fibrosis score
(3 times)
Gastroenterology
(3 times)
CK18 (1 time)
NAS (1 time)
NASH (1 time)
2014 Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study.
20  etoposide, leucovorin, and 5-FU
(3 times)
Neoplasms
(2 times)
EAP (2 times)
5-FU (1 time)
CRs (1 time)
1991 New developments in the treatment of gastric carcinoma.
21  extra-low-frequency
(3 times)
Physiology
(1 time)
AMPK (1 time)
ATPS (1 time)
CaM (1 time)
1996 Extra low frequency electric and magnetic fields in the bedplace of children diagnosed with leukaemia: a case-control study.
22  extremely-low-frequency range
(3 times)
Medicine
(1 time)
EMF (1 time)
ICNIRP (1 time)
NRPB (1 time)
1992 Experimental macroscopic dosimetry for extremely-low-frequency electric and magnetic fields.
23  E. coli laminin-binding fimbriae
(2 times)
Microbiology
(2 times)
aEPEC (1 time)
ECP (1 time)
HCP (1 time)
2009 The Escherichia coli ycbQRST operon encodes fimbriae with laminin-binding and epithelial cell adherence properties in Shiga-toxigenic E.  coli O157:H7.
24  early limited formula
(2 times)
Pediatrics
(2 times)
--- 2013 Effect of early limited formula on duration and exclusivity of breastfeeding in at-risk infants: an RCT.
25  early-life fecundity
(2 times)
Biology
(2 times)
AP (1 time)
2008 Testing for genetic trade-offs between early- and late-life reproduction in a wild red deer population.
26  elastic light scattering fingerprinting
(2 times)
Biochemistry
(2 times)
AUROC (1 time)
LEBS (1 time)
2005 Spectral markers in preneoplastic intestinal mucosa: an accurate predictor of tumor risk in the MIN mouse.
27  electrodeless Lorentz force
(2 times)
Biomedical Engineering
(1 time)
--- 2012 The electrodeless Lorentz force (ELF) thruster experimental facility.
28  electromagnetic field
(2 times)
Technology
(1 time)
TAMMEF (1 time)
1985 A role for Ca2+ in the effect of very low frequency electromagnetic field on the blastogenesis of human lymphocytes.
29  electromagnetic fields
(2 times)
Occupational Medicine
(1 time)
EGF (1 time)
HOK (1 time)
SEM (1 time)
2003 [Experimental data on extremely low frequency (ELF) electromagnetic fields].
30  endoscopic laser foraminoplasty
(2 times)
Neurosurgery
(1 time)
CIA (1 time)
MRI (1 time)
SPSS (1 time)
1998 Endoscopic laser foraminoplasty on the lumbar spine--early experience.
31  endoscopic lumbar foraminotomy
(2 times)
Neurosurgery
(2 times)
FA (1 time)
FH (1 time)
ICC (1 time)
2014 Percutaneous endoscopic lumbar foraminotomy: an advanced surgical technique and clinical outcomes.
32  epithelial fluid
(2 times)
Pharmaceutical Preparations
(1 time)
AMs (1 time)
AUC (1 time)
TEL (1 time)
1992 Quantitative assessment of epithelial lining fluid in the lung.
33  esterified lactoferrin
(2 times)
Chemistry
(1 time)
LF (2 times)
PR (1 time)
TMV (1 time)
2012 Effects of esterified lactoferrin and lactoferrin on control of postharvest blue mold of apple fruit and their possible mechanisms of action.
34  etoposid plus leucovorin plus 5-FU
(2 times)
Medicine
(1 time)
5-FU (2 times)
EAP (2 times)
ECF (2 times)
1996 Chemotherapy of gastric cancer.
35  etoposide plus 5-fluorouracil plus leucovorin
(2 times)
Antineoplastic Agents
(1 time)
EAP (2 times)
FAM (2 times)
FP (1 time)
1991 Perspectives in chemotherapy of advanced gastric cancer.
36  European liver fibrosis
(2 times)
Gastroenterology
(2 times)
AUROC (1 time)
CHC (1 time)
NAFLD (1 time)
2011 Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.
37  extremely low-frequency electric
(2 times)
Environmental Health
(1 time)
CAs (1 time)
MN (1 time)
2009 A biomonitoring study of genotoxic risk to workers of transformers and distribution line stations.
38  E2-like fold
(1 time)
Biochemistry
(1 time)
FA (1 time)
ICL (1 time)
2015 The Fanconi Anemia DNA Repair Pathway Is Regulated by an Interaction between Ubiquitin and the E2-like Fold Domain of FANCL.
39  ear lobe free
(1 time)
Anthropology
(1 time)
HC (1 time)
NC (1 time)
RH (1 time)
2015 Frequency Distribution and Association of some Morpho- and Physiological Traits in Patients with Lung Diseases in Kosova.
40  Early Listening Function
(1 time)
Otolaryngology
(1 time)
ABEL (1 time)
CHAPS (1 time)
CHILD (1 time)
2018 Quality of questionnaires for the assessment of otitis media with effusion in children.
41  Effectiveness of Lumbopelvic Feedback
(1 time)
Medicine
(1 time)
ANCOVA (1 time)
LBP (1 time)
PMF (1 time)
2017 Effectiveness of a lumbopelvic monitor and feedback device to change postural behaviour: a protocol for the ELF cluster randomised controlled trial.
42  egg-laying females
(1 time)
Pi (1 time)
RF (1 time)
2010 Relationships between initial population densities of Meloidogyne incognita race 2 and nematode population development in terms of variable soybean resistance.
43  ejector-loop fermenter
(1 time)
Biomedical Engineering
(1 time)
--- 1983 The ejector-loop fermenter: Description and performance of the apparatus.
44  electric and magnetic fields
(1 time)
Environmental Health
(1 time)
AFs (1 time)
2006 Public health impact of extremely low-frequency electromagnetic fields.
45  electric fields
(1 time)
Biomedical Research
(1 time)
RAPD (1 time)
Rf (1 time)
SDS-PAGE (1 time)
2015 Evaluation of Genetic Variations in Maize Seedlings Exposed to Electric Field Based on Protein and DNA Markers.
46  electrical lead failure
(1 time)
Cardiology
(1 time)
TLE (1 time)
2018 Analysis of electrical lead failures in patients referred for transvenous lead extraction procedures.
47  ElectroForce
(1 time)
Physiology
(1 time)
--- 2015 Dynamic and quasi-static mechanical testing for characterization of the viscoelastic properties of human uterine tissue.
48  element tandems with FLAG sequence
(1 time)
Botany
(1 time)
ncRNA (1 time)
pol (1 time)
scRNA (1 time)
2010 Pol II-directed short RNAs suppress the nuclear export of mRNA.
49  elevated liver fat content
(1 time)
Obesity
(1 time)
GRS (1 time)
2013 Genetic and clinical markers of elevated liver fat content in overweight and obese Hispanic children.
50  ELF rho
(1 time)
Chemistry
(1 time)
AdNDP (1 time)
CMOs (1 time)
2010 Quantitative characteristics of qualitative localized bonding patterns.
51  Eliminate Legal size Files
(1 time)
--- 1982 Project ELF (Eliminate Legal size Files): the 25% solution to business expenses!
52  elongation factor-1alpha
(1 time)
Rheumatology
(1 time)
EthBr (1 time)
G3PDH (1 time)
OA (1 time)
1999 A comparison of various "housekeeping" probes for northern analysis of normal and osteoarthritic articular cartilage RNA.
53  endogenous losses of fat
(1 time)
Veterinary Medicine
(1 time)
ATTD (1 time)
TTTD (1 time)
2010 Effect of the form of dietary fat and the concentration of dietary neutral detergent fiber on ileal and total tract endogenous losses and apparent and true digestibility of fat by growing pigs.
54  English language frontend
(1 time)
Natural Science Disciplines
(1 time)
NLIDBs (1 time)
2016 Comparative study on the customization of natural language interfaces to databases.
55  Enhanced Liver Function
(1 time)
Medicine
(1 time)
ARFI (1 time)
TE (1 time)
2015 Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients.
56  Enzyme-Labeled Fluorescent alkaline phosphatase substrate
(1 time)
Histocytochemistry
(1 time)
FISH (1 time)
NPY (1 time)
POMC (1 time)
2000 Fluorescence in situ hybridization of scarce leptin receptor mRNA using the enzyme-labeled fluorescent substrate method and tyramide signal amplification.
57  enzyme-labeled fluorescent substrate
(1 time)
ALP (1 time)
TX-114 (1 time)
2012 PARTIAL PURIFICATION AND CHARACTERIZATION OF A CALCIUM-DEPENDENT ALKALINE PHOSPHATASE FROM THE CYANOBACTERIUM ARTHROSPIRA PLATENSIS (1).
58  enzyme-labile fraction
(1 time)
Nutritional Sciences
(1 time)
RSF (1 time)
TUF (1 time)
2000 Enzymatic assay to determine collagen thermal denaturation and solubilization.
59  eph ligand family
(1 time)
Cell Biology
(1 time)
RTKs (1 time)
1996 Embryonic expression of eph signalling factors in Xenopus.
60  epithelial lining fluid and cells
(1 time)
Biology
(1 time)
BALF (1 time)
EBC (1 time)
IS (1 time)
2014 Proteomic analysis of the asthmatic airway.
61  Epithelial lining fluid volume
(1 time)
General Surgery
(1 time)
BAL (1 time)
IL (1 time)
LDH (1 time)
2003 Effect of ventilatory rate on airway cytokine levels and lung injury.
62  epithelium is lined by a fluid
(1 time)
Pathology
(1 time)
BAL (1 time)
2005 Use of bronchoalveolar lavage to detect respiratory tract toxicity of inhaled material.
63  equine lactoferrin
(1 time)
Molecular Biology
(1 time)
--- 2002 Expression, purification, and characterization of equine lactoferrin in Pichia pastoris.
64  established liver fibrosis
(1 time)
Medicine
(1 time)
HCV (1 time)
PFD (1 time)
2008 Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment.
65  estimating the latent FDR
(1 time)
Medical Informatics
(1 time)
FDR (1 time)
2006 Estimation of false discovery proportion under general dependence.
66  etoposide plus 5-FU/LV
(1 time)
Neoplasms
(1 time)
5-FU (1 time)
CI (1 time)
ILF (1 time)
2005 Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer.
67  etoposide, 5-fluorouracil, and folinic acid
(1 time)
Neoplasms
(1 time)
GM-CSF (1 time)
i.v (1 time)
1999 Combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma.
68  etoposide/folinic acid/5-fluorouracil
(1 time)
Antineoplastic Agents
(1 time)
--- 1991 Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer.
69  etoposide/leucovorin/5-FU
(1 time)
Neoplasms
(1 time)
5-FU (1 time)
DLT (1 time)
1999 CPT-11 in gastrointestinal cancer.
70  European Liver Fibrosis panel
(1 time)
Gastroenterology
(1 time)
APRI (1 time)
FIB4 (1 time)
LSM (1 time)
2014 Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.
71  European Lung Foundation
(1 time)
ERS (1 time)
2018 What do patients know? Education from the European Lung Foundation perspective.
72  Excluded Letter Fluency
(1 time)
Neurology
(1 time)
PD (1 time)
2013 A novel bedside task to tap inhibitory dysfunction and fronto-striatal atrophy in Parkinson's disease.
73  extended-Lagrangian free energy calculation
(1 time)
Chemistry
(1 time)
CV (1 time)
eABF (1 time)
egABF (1 time)
2018 ELF: An Extended-Lagrangian Free Energy Calculation Module for Multiple Molecular Dynamics Engines.
74  extra-luminal flow
(1 time)
Biomedical Engineering
(1 time)
--- 1998 [Design and laboratory manufacture of "SUU-Type I" extra-luminal flow hollow fibre membrane oxygenator with microporous polypropylene].
75  Extract Landmark Features
(1 time)
Biology
(1 time)
--- 2018 ELF: Extract Landmark Features by optimizing topology maintenance, redundancy, and specificity.
76  extracts of Ligularia fischeri
(1 time)
Medicine
(1 time)
HCD (1 time)
2019 Antihyperlipidemic Activity of Ligularia fischeri Extract in Mice Fed a High-Carbohydrate Diet.
77  extralesional skin fibroblasts
(1 time)
Dermatology
(1 time)
EL (1 time)
Jag-1 (1 time)
KD (1 time)
2012 Notch signaling pathway in keloid disease: enhanced fibroblast activity in a Jagged-1 peptide-dependent manner in lesional vs. extralesional fibroblasts.
78  EXTREMELY LOW FREQUENCIES
(1 time)
Medicine
(1 time)
ELF-MF (1 time)
2015 [TECHNICAL ASPECTS OF EXPOSURE TO MAGNETIC FIELDS OF EXTREMELY LOW FREQUENCIES (ELF) IN BIOMEDICAL RESEARCH].
79  low-frequency energy
(1 time)
Technology
(1 time)
EEMD (1 time)
EHF (1 time)
IMF (1 time)
2017 [Time-frequency Research of Pulse Rate Variability Based on the EEMD].
80  plasma-to-epithelial lining fluid
(1 time)
Pharmacology
(1 time)
cIAIs (1 time)
cUTIs (1 time)
MICs (1 time)
2016 Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia.